Works matching IS 19466234 AND DT 2011 AND VI 3 AND IP 64
Results: 3
Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 64, p. 1, doi. 10.1126/scitranslmed.3001385
- By:
- Publication type:
- Article
The p53 Pathway as a Target in Cancer Therapeutics: Obstacles and Promise.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 64, p. 1, doi. 10.1126/scitranslmed.3001366
- By:
- Publication type:
- Article
Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 64, p. 1, doi. 10.1126/scitranslmed.3001708
- By:
- Publication type:
- Article